Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiomyopathy, Familial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00294671
What this trial is testing

The Effect of Diflunisal on Familial Amyloidosis

Who this might be right for
Familial Amyloid PolyneuropathyFamilial Amyloidosis
Boston University 130
Large-scale testing (Phase 3)Active Not RecruitingNCT04153149
What this trial is testing

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals 655
Not applicableEnrolling By InvitationNCT07339007
What this trial is testing

Observational Study to Validate a Family Physician Echocardiography Training Programme

Who this might be right for
Heart FailureValvular Heart DiseasesAtrial Fibrillation (AF)+2 more
Societat Catalana de Medicina Familiar i Comunitària, Assoc. (CAMFiC) 500
Not applicableUnknownNCT05699044
What this trial is testing

Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation

Who this might be right for
Amyloid CardiomyopathyBlock, AV
Steen Hvitfeldt Poulsen 170
Testing effectiveness (Phase 2)Study completedNCT04766892
What this trial is testing

Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Bristol-Myers Squibb 30
Not applicableStudy completedNCT00001225
What this trial is testing

Family Studies of Inherited Heart Disease

Who this might be right for
Hypertrophic Cardiomyopathy
National Heart, Lung, and Blood Institute (NHLBI) 5,880
Testing effectiveness (Phase 2)Active Not RecruitingNCT03536767
What this trial is testing

Open-Label Study of AG10 in Patients with Cardiomyopathy

Who this might be right for
Amyloid Cardiomyopathy
Eidos Therapeutics, a BridgeBio company 55
Not applicableLooking for participantsNCT05098665
What this trial is testing

PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

Who this might be right for
Cardiac Amyloidosis
Richmond Research Institute 320
Not applicableStudy completedNCT02908724
What this trial is testing

Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy

Who this might be right for
Fabry Disease
Ulla Feldt-Rasmussen 66
Not applicableEnded earlyNCT00322582
What this trial is testing

The Genetic Basis for Familial Cardiomyopathy in Patients With Idiopathic Cardiomyopathy

Who this might be right for
Cardiomyopathy
Carmel Medical Center 41
Not applicableStudy completedNCT00001881
What this trial is testing

Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease

Who this might be right for
Cardiomyopathy, Hypertrophic, Familial
National Heart, Lung, and Blood Institute (NHLBI) 9,999
Large-scale testing (Phase 3)Ended earlyNCT02291237
What this trial is testing

Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Gilead Sciences 172
Not applicableStudy completedNCT03090425
What this trial is testing

Inflammatory/Familial Dilated Cardiomyopathy: Is There a Link to Autoimmune Diseases? TP9a

Who this might be right for
Non Ischemic Cardiomyopathy
Philipps University Marburg 320
Not applicableStudy completedNCT05795400
What this trial is testing

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction+1 more
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Large-scale testing (Phase 3)Ended earlyNCT01583114
What this trial is testing

PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors

Who this might be right for
Dilated Cardiomyopathy
Institut National de la Santé Et de la Recherche Médicale, France 6
Testing effectiveness (Phase 2)Ended earlyNCT02862600
What this trial is testing

Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure

Who this might be right for
Cardiomyopathy, HypertrophicCardiomyopathy, Hypertrophic, Familial
Heart Metabolics Limited 35
Not applicableLooking for participantsNCT07196839
What this trial is testing

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
University of Texas Southwestern Medical Center 50
Not applicableUnknownNCT01714674
What this trial is testing

Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Maastricht University Medical Center 10
Not applicableStudy completedNCT03431896
What this trial is testing

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

Who this might be right for
AmyloidosisAmyloidAmyloid Neuropathies, Familial+4 more
The Cleveland Clinic 37
Testing effectiveness (Phase 2)Study completedNCT03458130
What this trial is testing

Study of AG10 in Amyloid Cardiomyopathy

Who this might be right for
Familial ATTR-CM (ATTRm-CM, or FAC)Wild-type ATTR-CM (ATTRwt-CM)
Eidos Therapeutics, a BridgeBio company 49
Next Page